XML 26 R17.htm IDEA: XBRL DOCUMENT v3.23.1
ACCOUNTS PAYABLE AND ACCRUED EXPENSES
3 Months Ended
Mar. 31, 2022
Payables and Accruals [Abstract]  
ACCOUNTS PAYABLE AND ACCRUED EXPENSES

11. ACCOUNTS PAYABLE AND ACCRUED EXPENSES

 

Other current liabilities at March 31, 2022 and December 31, 2021 consisted of:

 

  March 31,   December 31, 
   2022   2021 
 Accounts payable  $11,448,000   $6,902,000 
 Accrued payroll and payroll taxes   4,364,000    5,027,000 
 Financial instrument liabilities   4,267,000    4,249,000 
 Accrued legal   1,787,000    2,637,000 
 Other accrued expenses   5,373,000    3,940,000 
   $ 27,239,000  $22,755,000

 

Financial Instruments

 

Under authoritative guidance used by the FASB on determining whether an instrument (or embedded feature) is indexed to an entity’s own stock, instruments that do not have fixed settlement provisions are deemed to be derivative instruments. In prior years, the Company granted certain warrants that resulted in these warrants accounted for as a financial instrument and being re-measured every reporting period with the change in value reported in the statement of operations.

 

The financial instruments were valued using a variety of pricing models with the following valuation assumptions:

 

  March 31,
2022
   December 31,
2021
 
Contractually stipulated stock price  $2.50   $2.50 
Exercise price  $2.50   $2.50 
Contractually defined remaining term   5.0    5.0 
Contractually defined volatility   135%   135%
Dividend yield   0%   0%
Risk-free interest rate   2.4%   1.3%

 

Per the terms of the warrant agreements underlying the financial instruments, the value to the warrant holders is defined within the agreement based on a stock price, contractual term, volatility factor and dividend rate as defined in the warrant agreement, and not indexed to the company’s stock, resulting in the financial instrument accounting. The risk-free interest rate was based on rates established by the Federal Reserve Bank.

 

The following table sets forth a summary of the changes in the estimated fair value of the financial instruments during the three months ended March 31, 2022 and 2021:

 

  March 31, 2022   March 31, 2021 
 Beginning balance  $4,249,000   $4,192,000 
 Change in fair value   18,000    679,000 
 Ending balance  $4,267,000   $4,871,000